Similarly, CD2 showed a positive correlation with CD58 in WHO II (r = 0.439, p < .001), WHO III (r = 0.615, p < .001), and WHO IV (r = 0.377, p < .001) gliomas in Figure 1C. Here, CD58 is linked to central nervous system cancer.